These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 189293)

  • 1. The role of peptides in the central nervous system function.
    Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):647-54. PubMed ID: 189293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of albumin degradation products (ADP) on the central action of catecholamines.
    Tarasiewicz S; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasoactive substance and the lung].
    Kitamura S
    Kokyu To Junkan; 1973 Aug; 21(8):688-700. PubMed ID: 4354545
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system.
    Wiśniewski K; Buczko W; Moniuszko-Jakoniuk J
    Acta Neurobiol Exp (Wars); 1975; 35(3):275-83. PubMed ID: 126007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of globulin degradation products (GDP) on some centrally acting drugs.
    Tarasiewicz S; Maćkowiak J; Moniuszko-Jakoniuk J; Michalak S
    Acta Med Pol; 1977; 18(2):113-21. PubMed ID: 883513
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotides and central cardiovascular control in the cat [proceedings].
    Clipsham PJ; Hamilton TC; Hunt AE; Poyser RH
    Br J Pharmacol; 1978 Nov; 64(3):395P. PubMed ID: 214195
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J; Buczko W
    Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of kinins via microglia in the central nervous system.
    Noda M; Kettenmann H; Wada K
    Biol Chem; 2006 Feb; 387(2):167-71. PubMed ID: 16497148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 11. CNS and ACTH-like peptides: neurochemical response and interaction with opiates.
    Gispen WH; Reith ME; Schotman P; Wiegant VM; Zwiers H; de Wied D
    Adv Biochem Psychopharmacol; 1977; 17():61-80. PubMed ID: 200081
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropeptides and central catecholamine systems: interactions in neuroendocrine and central cardiovascular regulation.
    Fuxe K; Andersson K; Locatelli V; Mutt V; Lundberg J; Hökfelt T; Agnati LF; Eneroth P; Bolme P
    Adv Biochem Psychopharmacol; 1980; 22():37-50. PubMed ID: 6156580
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs.
    Buczko W; Moniuszko-Jakoniuk J
    Pharmacology; 1975; 13(3):252-9. PubMed ID: 1153509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: comparative neurobiology of peptidergic systems.
    Strumwasser F
    Fed Proc; 1982 Nov; 41(13):2919-22. PubMed ID: 6128260
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
    Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(5):473-80. PubMed ID: 575732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of albumin degradation products (ADP) on the action of acetylcholine in the central nervous system.
    Buczko W; Józefów D; Ostaszewska-Puchajda B
    Acta Med Pol; 1979; 20(3):173-9. PubMed ID: 517158
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of fibrinogen degradation products (FDP) on the central action of acetylcholine.
    Zadrozna B; Buczko W
    Pol J Pharmacol Pharm; 1976; 28(6):679-84. PubMed ID: 1012988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of trypsin-degradation products of albumin on the activity of the central nervous system.
    Sobaniec W; Buczko W; Moniuszko-Jakoniuk J
    Acta Neurobiol Exp (Wars); 1975; 35(1):93-101. PubMed ID: 1136871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The conformation of natural peptides and their biological activity].
    Siemion IZ
    Postepy Hig Med Dosw; 1973; 27(3):311-27. PubMed ID: 4352819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.